This inventor holds 1 USPTO granted patent. Top assignee: Japan Tobacco Inc.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Toru Noguchi: Innovator in Hepatitis C Treatment
Introduction
Toru Noguchi is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target hepatitis C.
Latest Patents
One of his key patents is for a piperazine compound and its use as an HCV polymerase inhibitor. This invention relates to a compound represented by a specific formula, which is effective as an anti-HCV agent. The compound demonstrates anti-HCV activity based on its inhibitory effects on HCV polymerase, making it a valuable option for the prophylaxis or treatment of hepatitis C. He holds 1 patent related to this innovative work.
Career Highlights
Toru Noguchi is associated with Japan Tobacco Inc., where he has been involved in research and development efforts aimed at combating hepatitis C. His work has contributed to advancements in the pharmaceutical industry, particularly in the area of antiviral agents.
Collaborations
He has collaborated with notable colleagues such as Akira Suma and Makoto Shiozaki, enhancing the research and development process through teamwork and shared expertise.
Conclusion
Toru Noguchi's contributions to the field of hepatitis C treatment through his innovative patent highlight his role as a significant inventor in the pharmaceutical industry. His work continues to impact the development of effective treatments for this viral infection.